Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07070570

HAKA: Routine Follow-up at 10 Years After Hip- or Knee Arthroplasty: Wasting Resources or Appropriate Healthcare?

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,500 (estimated)
Sponsor
Reinier Haga Orthopedisch Centrum · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

After undergoing total hip or total knee arthroplasty, current guidelines recommend routine follow-up with an X-ray within 3 months and again at 1 year. Follow-up at 5 years (for hip arthroplasties) or every 5 years (for knee arthroplasties) is also considered worthwhile according to the guideline. However, these follow-up appointments require considerable time from patients, caregivers, and healthcare professionals, and it is unclear whether they are truly beneficial. It is possible that a single follow-up within 3 months is sufficient. This could potentially prevent over 100,000 unnecessary hospital visits per year, resulting in significant cost savings. If patients or healthcare providers have concerns, they can always request an additional follow-up. The HAKA trial consists of three different work packages (WPs). This trial (WP2) investigates the 10-year follow-up, WP1 examines the 1-year follow-up, and WP3 is a qualitative study exploring the experiences and perceptions of patients and healthcare professionals. The aim of the HAKA trial is to safely reduce routine follow-up appointments after total hip or knee arthroplasty and to revise current clinical guidelines accordingly.

Conditions

Interventions

TypeNameDescription
OTHERRoutine Follow-Up (RFU)Standard follow-up care with scheduled X-ray, clinical visit and questionnaires at 10 years after surgery
OTHERActive Check-Up on Demand (ACOD)X-ray, clinical visit and questionnaires at 10 years after surgery when requested by the patient or healthcare provider.
OTHERPassive Check-Up on Demand (PCOD)X-ray and clinical visit (without questionnaires) at 10 year when requested by the patient or healthcare provider.

Timeline

Start date
2025-09-01
Primary completion
2028-08-31
Completion
2029-12-31
First posted
2025-07-17
Last updated
2025-07-17

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT07070570. Inclusion in this directory is not an endorsement.